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The targeting of type III secretion (TTS) proteins at
the injectisome is an important process in bacterial
virulence. Nevertheless, how the injectisome specif-
ically recognizes TTS substrates among all bacterial
proteins is unknown. A TTS peripheral membrane
ATPase protein located at the base of the injectisome
has been implicated in the targeting process. We
have investigated the targeting of the EspA filament
protein and its cognate chaperone, CesAB, to the
EscN ATPase of the enteropathogenic E. coli
(EPEC). We show that EscN selectively engages the
EspA-loaded CesAB but not the unliganded CesAB.
Structure analysis revealed that the targeting signal
is encoded in a disorder-order structural transition
in CesAB that is elicited only upon the binding of
its physiological substrate, EspA. Abrogation of the
interaction between the CesAB-EspA complex and
EscN resulted in severe secretion and infection
defects. Additionally, we show that the targeting
and secretion signals are distinct and that the
two processes are likely regulated by different mech-
anisms.
INTRODUCTION
The type III secretion (TTS) system is a multiprotein machinery
that has evolved to deliver bacterial virulence proteins directly
into eukaryotic cells through an organelle termed the injectisome
(Cornelis, 2006; Gala´n and Wolf-Watz, 2006). The TTS
substrates (needle-forming proteins, effectors, and transloca-
tors) are targeted to the cytoplasmic base of the injectisome
and hierarchically secreted through the channel (Izore´ et al.,
2011). In the cytosol, TTS substrates are typically found as
complexes with their cognate chaperones (Birtalan et al., 2002;
Page and Parsot, 2002; Feldman and Cornelis, 2003; Francis,
2010), which have established roles as antiaggregation andstabilizing factors for TTS substrates. It has been hypothesized
that chaperones may also act as signals for targeting and hier-
archy-determining factors (Birtalan et al., 2002; Lilic et al.,
2006; Rodgers et al., 2010; Lara-Tejero et al., 2011).
A key protein in TTS systems is the ATPase (Woestyn et al.,
1994; Pallen et al., 2005), a peripheral membrane protein located
at the entrance of the injectisome. Biochemical experiments
have provided evidence that the TTS ATPase protein, which is
ubiquitous to all TTS systems, may serve to recognize and
engage the TTS proteins at the injectisome (Gauthier and Finlay,
2003; Akeda and Gala´n, 2005; Thomas et al., 2005; Boonyom
et al., 2010; Cooper et al., 2010). The ATPase is located at the
cytoplasmic base of the injectisome and forms a ring structure
(Mu¨ller et al., 2006) that resembles the F1F0-ATPase (Pallen
et al., 2006; Imada et al., 2007; Zarivach et al., 2007). The molec-
ular basis for the targeting of TTS substrates to the ATPase
remains completely unknown.
We studied this targeting process in enteropathogenic E. coli
(EPEC), the archetype of a group of pathogens that adhere to
host enterocytes via the formation of attaching and effacing
lesions and cause extensive host cell cytoskeletal rearrange-
ments (Dean andKenny, 2009).When secreted, EspA undergoes
self-polymerization, thereby forming a long extracellular filamen-
tous extension that coats the needle and connects it to the trans-
location pore in the eukaryotic plasma membrane, and most
likely acts as a molecular conduit for TTS protein translocation
(Knutton et al., 1998). EspA has a high tendency to self-oligomer-
ize and, thus, is retained in a monomeric, soluble state in the
cytoplasm by forming a complex with the CesAB chaperone
(Creasey et al., 2003; Yip et al., 2005).
Here, we show that the homodimeric CesAB chaperone exists
in a partially unfolded state and does not interact with the EscN
ATPase. In contrast, the formation of the CesAB-EspA chap-
erone-substrate complex results in a strong affinity for EscN.
Structural analysis demonstrated that the binding of EspA to
CesAB results in the extensive folding of many regions in the
chaperone. The induced structure in one of these regions is
specifically recognized by EscN, and it mediates the formation
of the ternary EscN-CesAB-EspA complex. Interestingly, a ho-
modimeric CesAB variant designed to adopt a folded structureCell Reports 3, 709–715, March 28, 2013 ª2013 The Authors 709
Figure 1. Structures of CesAB, CesAB-EspA, and CesABs
(A) The solution structure of the homodimeric CesAB, which adopts a molten-globule-like structure in solution (Chen et al., 2011).
(B) The 1H-15N HSQC spectrum of CesAB.
(C) The crystal structure of the heterodimeric CesAB-EspA (Yip et al., 2005). Regions of the proteins that were not crystallographically resolved are represented as
dotted lines.
(D) The 1H-15N HSQC spectrum of CesAB-EspA. The CesAB subunit is 15N labeled, whereas the EspA subunit is unlabeled.
(E) The solution structure of the CesABs variant (D14L-R18D-E20L), as determined in this work.
(F) The 1H-15N HSQC spectrum of CesABs.
(G) Superposition of the CesAB subunit of CesAB, CesAB-EspA, and CesABs.similar to the one induced by EspA binding is capable of interact-
ing with EscN. Amino acid substitutions in the EscN-interacting
CesAB region abrogate the targeting of CesAB-EspA to EscN,
resulting in severe secretion and infection defects.
RESULTS
The Substrate-Free CesAB Chaperone Does Not
Interact with the EscN ATPase
In the absence of its substrate EspA, CesAB exists as a loosely
packed, conformationally dynamic homodimer in solution
(Chen et al., 2011) (Figures 1A and 1B). CesAB adopts a four-710 Cell Reports 3, 709–715, March 28, 2013 ª2013 The Authorshelix bundle structure with each of the subunits in an all-helical
conformation consisting of three helices of variable stability
(Chen et al., 2011) (Figure 1A). We used nuclear magnetic
resonance (NMR) spectroscopy, which is a very sensitive
reporter of even transient binding interactions (Takeuchi and
Wagner, 2006), to test whether CesAB interacts with the
ATPase EscN (Gauthier and Finlay, 2003; Zarivach et al.,
2007). For this reason, we prepared full-length EscN, which,
as we show here, forms a stable hexamer in solution with stim-
ulated ATPase activity (Figures S2A and S2C). The NMR data
show that none of the CesAB resonances are affected by the
addition of EscN (Figure S2D), thereby demonstrating that there
Figure 2. Interaction of CesAB-EspA with EscN
(A) Overlaid 1H-15N HSQC spectra of the titration of U-2H-15N-labeled CesAB-EspA with unlabeled hexameric EscN. Stepwise addition of EscN results in gradual
resonance broadening of the interacting residues in CesAB-EspA. Spectra recorded at ten different titration points are overlaid. The CesAB residues most
affected by EscN binding are shown. The resonances not affected by EscN binding even at saturating concentrations of EscN are located in flexible regions of
EspA that were crystallographically unresolved.
(B) CesAB-EspA residues (shown in red sticks) identified by NMR to be most affected upon binding to EscN. All residues are located in helices a2 and a3 in
CesAB.
(C) Superposition of the CesAB subunit of the homodimeric CesAB (blue) and the heterodimeric CesAB-EspA complex (green). The residues identified to mediate
the binding of CesAB-EspA to EscN are shown.is no interaction between CesAB and EscN. Thus, CesAB
appears not to be engaged by the injectisome ATPase in its
substrate-free form.
The CesAB-EspA Heterodimer Interacts Specifically
with the EscN ATPase
The CesAB dimer undergoes subunit exchange to interact with
its cognate substrate EspA, resulting in the formation of a 1:1
heterodimeric complex with a molecular mass of 33 kDa
(Figure 1C) (Yip et al., 2005; Chen et al., 2011). The complex
forms a four-helix bundle, and each protein contributes two
a helices. Interestingly, CesAB, which is poorly folded in the ho-
modimer, acquires a well-folded structure upon binding to EspA
(Chen et al., 2011) (Figures 1C and 1D). We used NMR to test the
interaction between CesAB-EspA and hexameric EscN. The
NMR data show that the addition of EscN causes a very signifi-
cant effect on a large number of CesAB-EspA resonances
(Figures 2A and S2E), indicating the formation of the ternary
CesAB-EspA-EscN complex. The dissociation constant (Kd) of
the ternary complex, measured by NMR line-shape analysis, is
3 mM. Thus, the heterodimeric chaperone-substrate complex
binds with a significant affinity to the active hexameric state of
the injectisome ATPase. Interestingly, no binding was observed
between CesAB-EspA and an N-terminal-truncated EscN
variant that lacks the first 98 residues (EscNDN) and exists in
a monomeric state and lacks enzymatic activity (Figures S2B,
S2C, and S2F). Thus, EscN has to be in a functional oligomeric
state in order to engage the chaperone-substrate complex.The CesAB-EspA Interaction with EscN Is Mediated by
CesAB
To determine the specific residues that mediate the interaction
between CesAB-EspA and EscN, we used NMR differential line
broadening analysis (Matsuo et al., 1999; Panchal et al., 2003;
Zamoon et al., 2005; Takeuchi and Wagner, 2006) (Figure 2A).
Because EscN has a large molecular mass (350 kDa), complex
formation with labeled CesAB-EspA results in severe line broad-
ening of the resonances. The broadening effect is related to the
chemical shift difference of the CesAB-EspA resonances
between the EscN-free and EscN-bound forms. Thus, with the
use of this method, the residues in CesAB-EspA that are most
affected by the formation of the ternary complex with EscN
can be identified.
These results indicate that the residuesmost affected by EscN
binding belong to CesAB. Specifically, Thr63, Tyr64, Arg68,
Ser73, Ser76, Lys80, and Thr84 of CesAB experience the stron-
gest effects (Figure 2B). These residues are located in helices a2
and a3 of CesAB in the heterodimer and form a contiguous
solvent-exposed surface. The NMR data strongly suggest that
this region forms the EscN-binding surface in CesAB-EspA.
It is of interest that CesAB, rather than EspA, appears to be
responsible for mediating the binding between CesAB-EspA
and EscN. This is surprising, given that CesAB in the homodimer
does not interact with EscN (Figure S2D). Structural analysis of
the CesAB homodimer and the CesAB-EspA heterodimer shows
that the CesAB protomer adopts a similar overall fold; however,
in the CesAB homodimer, all three a helices are much shorter,Cell Reports 3, 709–715, March 28, 2013 ª2013 The Authors 711
largely unwound, and more dynamic, in contrast to the CesAB-
EspA complex, wherein they are well folded (Figure 1G) (Yip
et al., 2005; Chen et al., 2011). Superposition of the CesAB struc-
tures of the homodimer and heterodimer shows that the EscN-
binding region in CesAB is well formed in the heterodimer but
extensively unfolded in the homodimer (Figure 2C).
A Well-Folded CesAB Homodimer Variant Binds
Specifically to EscN
The present results suggest that the binding of EspA to CesAB
poises CesAB for interaction with EscN by eliciting a disorder-
to-order transition that stabilizes the formation of a region that
is specifically recognized by EscN (Figure 2C). To test this
hypothesis further, we assessed the effect of a CesAB variant
that was previously shown to mimic the EspA binding effect
and stabilize a well-folded structure of the CesAB homodimer
(Chen et al., 2011). Specifically, the D14L-R18D-E20L triple
amino acid substitution optimizes coiled-coil interactions at the
CesAB helical bundle interface. The stabilized CesAB-D14L-
R18D-E20L (henceforth CesABs) has NMR and circular
dichroism (CD) features that are characteristic of a well-folded
protein (Figures S1A–S1D).
We determined the solution structure of CesABs using NMR
(Figures 1E, 1F, and S1E and Table S1). CesABs adopts a struc-
ture that is, overall, very similar to that of CesAB (Figures 1G and
S1F). However, the packing at the helical bundle in CesABs is
drastically improved (Figure S1E), and CesABs buried
3,200 A˚2 in its dimeric interface, in comparison to only
1,100 A˚2 buried in CesAB.
Interestingly, the CesABs structure is very similar to the struc-
ture that CesAB adopts in the CesAB-EspA heterodimer (Figures
1G and S1G), and all three helices are well folded. Thus, the triple
mutant appears to induce the same structural transition to
CesAB that EspA binding induces. Most importantly, the EscN
binding region is well formed in CesABs. We used NMR to
assess whether CesABs interacts with EscN. The results clearly
show that there is a specific interaction between CesABs and
EscN (Figure S2G), the Kd of the ternary complex being esti-
mated at 12 mM. The residues most affected upon complex
formation are very similar in CesABs and CesAB-EspA (Figures
S1H and S1I). Altogether, the results show that the triple-
amino-acid substitution in CesABs induces an overall structure
to CesAB that is similar to the structure induced by EspA
binding, and, as a result, EscN specifically recognizes CesABs
and not CesAB.
Disruption of CesA~BEspA Binding to EscN Gives Rise to
Secretion and Functional Defects
To test the binding between CesAB-EspA and EscN, we gener-
ated CesAB mutants. Amino acids in the region identified to
mediate the interaction (Figure 2B) were mutated, and their
effect on the formation of the CesAB-EspA-EscN ternary
complex was assessed by NMR and in vivo secretion assays
(Figure 3). The data showed that substitutions at Glu60,
Tyr64, Arg68, and Lys69 substantially decrease the affinity of
CesAB-EspA for EscN. For example, the Kd of CesAB-EspA-
Y64A-R68A for EscN is larger than 80 mM, which is larger
than that of CesAB-EspA by more than a factor of 20. As712 Cell Reports 3, 709–715, March 28, 2013 ª2013 The Authorsa result of the much weaker interaction between the mutated
CesAB-EspA and EscN, secretion of EspA decreases substan-
tially (Figure 3B). In addition, infection of HeLa cells by EPEC
strains carrying cesAB mutated genes causes minimal actin
polymerization and pedestal formation, indicating the defective
secretion of TTS effectors (Figures 3C and 3D). It should be
noted that, in the absence of EscN, EspA is not secreted
(Figure S3). Collectively, these results provide strong evidence
that the efficient targeting of CesAB-EspA to EscN is required
for EspA secretion.
Targeting and Secretion Signals Are Distinct
It was previously shown that the first 20 N-terminal residues of
EspA bear a secretion signal for EspA, given that the deletion of
this region resulted in EspA secretion defects (Munera et al.,
2010). NMR analysis of the interaction of CesAB-EspA with
EscN (Figure 2A) shows that the N-terminal region of EspA
does not participate in the binding interaction. To corroborate
this further, we characterized the interaction of the isolated
N-terminal region of EspA (EspA1–34) with EscN by NMR. The
data showed that this region indeed does not interact with
EscN (Figure S2J). Additional evidence that the region of EspA
carrying the secretion signal does not participate in binding to
EscN was provided by NMR analysis of CesAB-EspAD29,
a variant comprising an N-truncated EspA lacking the first 29
residues. CesAB-EspAD29 retains the same fold and structure
as the full-length CesAB-EspA (Figure S2K) but is fully engaged
by EscN (Figure S2L). Thus, although EspA is targeted to the
ATPase by means of CesAB, there are regions in EspA that
control its secretion, most likely during a downstream process
following the targeting of EspA at the injectisome. These results
demonstrate that the targeting and secretion signals are distinct
and that the two processes are likely regulated by different
mechanisms.
DISCUSSION
The targeting of TTS secreted proteins at the injectisome is the
first crucial step in a process that ultimately results in the secre-
tion of needle and translocator proteins or the translocation of
effectors into the eukaryotic cell. The cytosolic basal structure
of the injectisome is capable of discerning the TTS substrates
from all the other bacterial proteins; yet, the molecular basis
for this process remains poorly understood. Here, we have iden-
tified the targeting signal in the EPEC CesAB-EspA chaperone-
substrate system. We show that the signal is encoded in
a conformational switch in the chaperone that is induced only
upon the binding of the physiological substrate (Figure 4). Our
results clearly demonstrate that chaperones contain targeting
signals and, thus, act to usher bound substrates to the
injectisome.
Several studies have focused on identifying the so-called
secretion signal, that is, the region of the TTS substrate that
controls its secretion (Mota et al., 2005). The results have sug-
gested, in certain cases, that specific sequences in the
N-terminal region of effectors and translocators constitute the
secretion signal (Sory et al., 1995; Lloyd et al., 2001; Amer
et al., 2011), whereas, in other cases, it has been suggested
Figure 3. Disruption of CesAB-EspA
Binding to EscN Gives Rise to Secretion
and Functional Defects
(A) The effect of the Y64A-R68A substitution on the
interaction of CesAB-EspA with EscN. Overlaid
1H-15N HSQC spectra of CesABY64A-R68A-EspA in
the absence (blue) and presence (magenta) of
EscN. In comparison to wild-type CesAB-EspA
binding to EscN, the NMR data indicate a signifi-
cant decrease in the affinity of the ternary complex
(Kd is larger than 80 mM). The boxed areas show
the corresponding regions of the spectra of
CesAB-EspA (green) superimposed on the spectra
of its complex with EscN (red). Whereas the
majority of the peaks are broadened beyond
detection in the CesAB-EspA-EscN complex, they
are still present at a substantial intensity in the
CesABY64A-R68A-EspA-EscN complex.
(B) In vivo secretion of EspA from EPECDcesAB
strains complemented with pASK-IBA7 plasmids
expressing wild-type or mutated CesAB. The
graph reports the total amount of EspA secreted in
90 min after CesAB expression. Errors were
calculated from a triplicate experiment.
(C) In vivo infection of HeLa cells from
EPECDcesAB or EPECDescN strains com-
plemented with pASK-IBA7 plasmids expressing
wild-type or mutated CesAB. The graph reports
the percentage of HeLa cells infected after being
inoculated with bacteria for 90 min. Errors were
calculated from a triplicate experiment.
(D) The infection of HeLa cells by bacterial
EPECDcesAB strains complemented with plas-
mids expressing wild-type or mutant CesAB. The
results show very little actin pedestal formation,
indicating uninfected HeLa cells, after being inoc-
ulated with bacteria for 90 min.that the secretion signal is encoded in the messenger RNA
sequence (Anderson and Schneewind, 1997; Ramamurthi and
Schneewind, 2005). However, secretion is a complex process,
and targeting is just the first step of it. Indeed, here, we demon-
strate that the targeting and secretion of the CesAB-EspA chap-
erone-substrate system are controlled by different signals: the
targeting signal is encoded in the chaperone (CesAB), whereas
the secretion signal is located in the N-terminal region of EspA
(Munera et al., 2010). This region of EspA is not required for
binding to the ATPase but is required for its ultimate secretion,
a process that occurs after the chaperone-substrate complex
has been engaged by the injectisome.
The TTS ATPase is conserved in all TTS systems and is
thought to play important roles in both engaging TTS substrates
and in the secretion process (Gala´n, 2008). Our results show
that, in the EPEC system, the EscN ATPase functions as a dock-
ing platform for chaperone-substrate complexes. The interac-
tions are functional, given that the abrogation of binding causes
severe secretion and infection defects. However, it is likely that
additional proteins of the cytosolic basal body of the injectisome
may also function as docking points for TTS substrates (Diepold
et al., 2012).EXPERIMENTAL PROCEDURES
Protein Preparation
The cesAB and espA genes encoding the wild-type CesAB (B7UMC4_ECO27)
and the wild-type EspA (B7UM94_ECO27) were isolated and cloned as
described previously (Chen et al., 2011). The ATPase escN encoding EscN
(B7UMA6_ECO27) was isolated by PCR from cosmid pCVD462 (a gift from
J.B. Kaper) derived from the locus of enterocyte effacement of E2348/69
cloned into pCVD551 (McDaniel and Kaper, 1997) and were finally cloned
into pET16b. The mutants were constructed by site-directed mutagenesis
with the use of PfuUltra High-Fidelity DNA Polymerase (Quick-Change; Strata-
gene). The constructs were transformed in BL21(DE3) cells and grown at 37C,
and protein synthesis was induced by the addition of 0.5 mM of IPTG at A600
0.4. Isotopically labeled samples for NMR studies were prepared as
described previously (Gelis et al., 2007; Popovych et al., 2009). All protein
samples were purified over a nickel-chelating Sepharose column (GE Health-
care) followed by a Superdex 75 size exclusion column (GE Healthcare).
Differential Line Broadening NMR Experiments
Because EscN has a large molecular mass (350 kDa), complex formation
with labeled CesAB-EspA resulted in severe line broadening of the reso-
nances. The broadening effect depends on the chemical shift difference of
the CesAB-EspA resonances between the EscN-free and EscN-bound forms
(Matsuo et al., 1999). Thus, with the use of this method, the residues in CesAB-
EspA that are most affected by the formation of the ternary complex with EscNCell Reports 3, 709–715, March 28, 2013 ª2013 The Authors 713
Figure 4. Targeting of CesAB-EspA to the ATPase
Although CesAB carries the targeting signal (shown in red), this is presented to
EscN only when EspA is bound to CesAB by means of an induced confor-
mational switch on CesAB. As a result, EscN recognizes the restructured
CesAB region and engages the CesAB-EspA complex.can be identified. The experiments were performed with a concentration of
15N-labeled CesAB-EspA complex fixed at 0.2mMwhile an increasing amount
of unlabeled EscN was titrated. The concentration ratio of CesAB-EspA
complex to the ATPase EscN varied from 0.2 to 2 mM. The intensity of CesAB-
EspA resonances as a function of EscN concentration was measured in 2D
1H-15N HSQC spectra.
ATPase Activity Measured via Isothermal Titration Calorimetry
ATPase activity assays were performed via isothermal titration calorimetry on
a VP-ITC MicroCalorimeter (GE Healthcare) employing a multi-injection anal-
ysis protocol (Todd and Gomez, 2001; Bianconi, 2007). This methodology is
based on the observed proportionality between the rate of reaction (v) and
thermal power (dq/dt) generated upon titration of discrete substrate aliquots
into an enzyme solution. The rate of product formation is determined accord-






where V represents the sample cell volume and DHapp corresponds to the
molar reaction enthalpy. ATPase activity was monitored calorimetrically at
25C in a buffer comprised of 50 mM HEPES, 100 mM NaCl, 5 mM MgCl2,
and 5.0 mM b-mercaptoethanol adjusted to pH 7.5. In a typical calorimetric
assay, the reaction rate is monitored by titrating successive microliter aliquots
of ATP substrate into the sample cell containing EscN. The thermal power is
monitored for 60 s upon each substrate injection under a constant stirring
rate of 250 rpm. Assuming that the reaction proceeds via a steady-state
mode in which [substrate][ [enzyme], the differential power upon each addi-
tion of substrate represents the maximal enzyme reaction rate and is charac-
terized by an exothermic heat that remains nearly constant until the next injec-
tion. The thermal power data monitoring ATP hydrolysis is converted to the
turnover rate (mM s1) and plotted as a function of substrate concentration.
The reaction profiles depicted in Figure S2C employ initial substrate (ATP)
and enzyme (EscN) concentrations of 2.5 and 0.006 mM, respectively.
In Vivo Secretion from EPEC Strains and Infection of HeLa Cells
The assays were performed as described previously. Details can be found in
Extended Experimental Procedures.
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